Quipt Home Medical Corp. (Nasdaq: QIPT) has provided an update regarding the progress of its definitive arrangement agreement under which it will be purchased by 1567208 B.C. Ltd.
News of the acquisition plan broke in December, with Quipt at that time stating it had agreed to be acquired by affiliates of Kingswood Capital Management and Forager Capital Management.
The Form 8-K filed by Quipt with the Securities and Exchange Commission (SEC) on Jan. 26 provided additional detail, including the name of 1567208 B.C. Ltd., described as the purchaser and “a company existing under the laws of British Columbia.” REM Aggregator LLC, based in Delaware, was also named as the parent entity through which the purchaser will acquire all of the issued and outstanding common shares of Quipt for U.S. $3.65 per share in cash.
In its Form 8-K, Quipt stated, “At 11:59 p.m. on Jan. 22, 2026, the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the ‘HSR Act’) expired with respect to the transactions contemplated by the arrangement agreement. The expiration of the waiting period under the HSR Act satisfies one of the conditions to the closing of the arrangement agreement. The agreement remains subject to other customary closing conditions, including receipt of approval of Quipt’s shareholders.”
The filing was signed by Hardik Mehta, Quipt’s chief financial officer.
The SEC described the Form 8-K as a “current report” used by public companies, who “must report certain material corporate events on a more current basis. Form 8-K … is the report that companies must file with the SEC to announce major events that shareholders should know about.”
With the acquisition, Quipt — whose head offices are in Wilder, Kentucky — would become a privately held company.
